ITA improves quality of care and helps to ensure
evidence-based medicine is prescribed and followed

Beyond the healthcare debate, with whatever reforms are pursued, lies an irrefutable fact:  there’s “untapped potential,” as the Institute of Medicine says, to reduce costs and improve quality by following evidence-based practice. 

Nowhere is that more crucial than in critical illnesses such as cancer.  Treatment standards emerge constantly, variation in care is widespread, and new cancer guidelines average 16 years for broad adoption and payer reimbursement.  Patients suffer, and costs climb by tens and sometimes hundreds of thousands of dollars when care isn't evidence-based.

ITA Partners offers a proven solution, with disease-specific medical expertise and proprietary technology that aligns the delivery and reimbursement of quality care.

Treatment Plan Review — ITA begins with evidence-based intelligence that compares prescribed treatment to the latest standards.  We validate that patients receive and payers pay only for quality care, through an electronic, unbiased library of current treatment protocols and insurance plan language.

Case Management — Complex cases often are referred for ITA case management.  ITA nurses experienced in cancer provide individualized support to patients and families when they’re outside the doctors’ offices, while coordinating care across the entire medical team.

ITA Partners, Inc.® is the nation’s only independent, critical illness risk management company, managing all aspects of cancer treatment. Our disease-specific, expert doctors, nurses, and insurance analysts support delivery of quality care from diagnosis forward. ITA’s proprietary health information technology facilitates accuracy, transparency, efficiency, and scalability, and leads to informed decisions by patients, physicians, and payers.